Herzlia, Israel

Zurit Levine

USPTO Granted Patents = 31 

 

 

Average Co-Inventor Count = 9.5

ph-index = 8

Forward Citations = 343(Granted Patents)


Location History:

  • Herzeliya, IL (2013)
  • Herzliya, IL (2005 - 2016)
  • Herzlia, IL (2008 - 2016)
  • Herzliyya, IL (2015 - 2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Zurit Levine: Pioneering Innovations in Immunotherapy

Introduction

Zurit Levine is a prominent inventor based in Herzlia, Israel, who has significantly contributed to the field of biotechnology. With an impressive portfolio of 31 patents, Levine's work focuses primarily on developing innovative drug targets and biologics aimed at combating various forms of cancer. His inventions highlight advancements in immunotherapy and therapeutic antibodies, showcasing his dedication to addressing critical medical challenges.

Latest Patents

Among Zurit Levine's latest patents are groundbreaking inventions that explore the applications of polypeptides and polynucleotides as drug targets. One notable invention discusses a novel target for the production of immune and non-immune therapeutics and disease diagnosis. This patent includes therapeutic antibodies against antigens such as VSIG1, ILDR1, and C1ORF32, which have been identified as co-stimulatory family members differentially expressed in several cancers, including lung, ovarian, and colon cancers. The therapeutic applications extend to modulating B7 costimulation and contributing to treatments for autoimmunity.

Another significant patent revolves around C1ORF32-specific antibodies, including antibody fragments and compositions aimed at cancer treatment. This innovation illustrates Levine's commitment to developing targeted therapies that can potentially transform cancer treatment approaches.

Career Highlights

Zurit Levine's career is marked by a consistent pursuit of innovations that bridge the gap between research and practical therapeutic applications. He holds an extensive array of patents, depicting a profound understanding of target identification and drug development processes. His inventions not only advance scientific knowledge but also contribute to the creation of effective therapies to combat malignancies, ensuring a lasting impact on the medical field.

Collaborations

Throughout his career, Levine has collaborated with noteworthy professionals, including Amir Toporik and Michal Ayalon-Soffer. These collaborations have fostered an environment of innovation and discovery, significantly enriching the research output and enhancing the potential for real-world applications of their work.

Conclusion

Zurit Levine stands out as a leading inventor in the arena of immunotherapy, with a substantial portfolio that underscores his innovative spirit and commitment to addressing crucial health challenges. His work continues to pave the way for advancements in cancer treatment and diagnosis, promising a brighter future for patients around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…